Australian University Rankings Guide

Der Nervenarzt: Monatsschrift fuer alle Gebiete nervenaerztlicher Forschung und Praxis (ERA Journal)

Der Nervenarzt: Monatsschrift fuer alle Gebiete nervenaerztlicher Forschung und Praxis is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Der Nervenarzt: Monatsschrift fuer alle Gebiete nervenaerztlicher Forschung und Praxis issns are issn1: 0028-2804 issn2: 1433-0407.

The field covered by Der Nervenarzt: Monatsschrift fuer alle Gebiete nervenaerztlicher Forschung und Praxis as part of the evaluation of Australian university research excellence is:

Clinical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- Acta Anaesthesiologica Taiwanica
- Clinical Medicine
- Expert Review of Gastroenterology and Hepatology
- International Journal of Cancer and Clinical Research
- International Journal of Health and Ageing Management
- Journal of Craniovertebral Junction and Spine
- Journal of Cutaneous Pathology
- Journal of the American Society of Nephrology
- Magnetic Resonance Imaging
- Molecular Human Reproduction
- Obesity Surgery
- Open Access Emergency Medicine
- Osteoarthritis and Cartilage
- Personality and Mental Health: multidisciplinary studies from personality dysfunction to criminal behaviour
- Spinal Cord


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4